Return to content in this issue

 

Successful infusion of obinutuzumab by desensitization: A case of anaphylactic shock during desensitization

Kim KW1, Chung S1, Lee SY1,2, Yoon SS1, Kang HR1,2,3

1Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea
2Institute of Allergy and Clinical Immunology, Seoul National University Medical Research Center
3Drug Safety Monitoring Center, Seoul National University Hospital, Seoul, Korea

J Investig Allergol Clin Immunol 2020; Vol. 30(6)
doi: 10.18176/jiaci.0581

Key words: Desensitization, Obinutuzumab, Adverse reaction, Anaphylaxis